Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A risk-benefit analysis has been used to balance the risks to travellers of death from malaria against the toxicity of various drug regimens. The mortality of travellers who take no prophylaxis is estimated to be surprisingly low, and it is concluded that most travellers, even in areas of drug resistance should take only non-toxic drugs, such as a combination of chloroquine and proguanil.


Journal article



Publication Date





1256 - 1261


Africa, Antimalarials, Asia, Bayes Theorem, Drug Administration Schedule, Drug Evaluation, Drug Resistance, Microbial, Drug Therapy, Combination, Humans, Malaria, Plasmodium falciparum, Proguanil, Quinine, Risk, Travel, United Kingdom